354 related articles for article (PubMed ID: 6555189)
1. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
Tweardy DJ; Jacobs MR; Speck WT
J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
Jacobs MR; Kelly F; Speck WT
Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin.
Ward JI; Moellering RC
Antimicrob Agents Chemother; 1981 Aug; 20(2):204-7. PubMed ID: 6912777
[TBL] [Abstract][Full Text] [Related]
4. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.
Liñares J; Alonso T; Pérez JL; Ayats J; Domínguez MA; Pallarés R; Martín R
J Antimicrob Chemother; 1992 Sep; 30(3):279-88. PubMed ID: 1452492
[TBL] [Abstract][Full Text] [Related]
5. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
[TBL] [Abstract][Full Text] [Related]
6. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Liñares J; Perez JL; Garau J; Murgui L; Martín R
J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919
[TBL] [Abstract][Full Text] [Related]
7. World-wide development of antibiotic resistance in pneumococci.
Appelbaum PC
Eur J Clin Microbiol; 1987 Aug; 6(4):367-77. PubMed ID: 3311732
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Miller MA; LeFrock JL; Vercler MJ
Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
[TBL] [Abstract][Full Text] [Related]
9. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci.
Viladrich PF; Gudiol F; Liñares J; Rufi G; Ariza J; Pallares R
Am J Med; 1988 May; 84(5):839-46. PubMed ID: 3364443
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
Cormican MG; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
[TBL] [Abstract][Full Text] [Related]
13. Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.
Goldstein EJ; Cherubin CE; Corrado ML; Sierra MF
Rev Infect Dis; 1982; 4 Suppl():S406-10. PubMed ID: 6294791
[TBL] [Abstract][Full Text] [Related]
14. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.
Jacobs MR
Am J Med; 1999 May; 106(5A):19S-25S; discussion 48S-52S. PubMed ID: 10348060
[TBL] [Abstract][Full Text] [Related]
17. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
[TBL] [Abstract][Full Text] [Related]
18. Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
Johnson DM; Doern GV; Haugen TA; Hindler J; Washington JA; Jones RN
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):137-41. PubMed ID: 8902410
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
[TBL] [Abstract][Full Text] [Related]
20. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
